Author: Amara Maple

The landscape of modern endocrinology research is often characterized by high-stakes breakthroughs and the relentless pursuit of clinical solutions, yet at the heart of the laboratory experience lies an inescapable reality: the inevitability of failure. During the ENDO 2026 conference held in Chicago, Illinois, this often-taboo subject took center stage within the Professional Development tract.…

The United States Food and Drug Administration (FDA) has reached several major regulatory milestones in the final week of September, signaling a transformative period for endocrine medicine and rare disease treatment. These actions include the landmark approval of the first-ever therapy for MCT8 deficiency, the advancement of a new indication for breast cancer-related symptom management,…

On September 17, members of the Endocrine Society joined a broad coalition of medical researchers, patient advocates, and scientific organizations in Washington, D.C., for the 13th annual Rally for Medical Research. This high-profile day of advocacy brought together hundreds of stakeholders from across the United States to engage directly with members of Congress and their…

On September 11, the Endocrine Society formally submitted a comprehensive set of comments to the Centers for Medicare and Medicaid Services (CMS) regarding the proposed rule for the Calendar Year 2027 Medicare Physician Fee Schedule (MPFS). This annual regulatory update, which dictates the reimbursement landscape for services provided under Medicare Part B, remains a focal…

The landscape of endocrine medicine and rare disease therapeutics underwent significant shifts during the second week of October, marked by a series of regulatory milestones and clinical data disclosures from leading pharmaceutical innovators. From the recommendation of new treatments for pediatric growth disorders in Europe to the expedited development of disease-modifying therapies for type 1…

The relationship between sleep patterns and metabolic health has long been a subject of clinical inquiry, but a new longitudinal study has identified a specific and concerning correlation between extended sleep duration and the health of the kidneys in patients with type 2 diabetes. According to research recently published in the Journal of the Endocrine…

The human endocrine system is a delicate network of glands and hormones that regulates nearly every biological process, from metabolism and growth to reproduction and cognitive function. However, this system is increasingly under siege from a ubiquitous class of industrial substances known as endocrine-disrupting chemicals (EDCs). As part of a pediatric health initiative, a series…

The Endocrine Society’s Bone and Mineral Special Interest Group (SIG) Steering Committee has issued a call to action for the global medical community to address the persistent diagnostic gap surrounding hypophosphatasia (HPP), a rare and often debilitating inherited metabolic disorder. Ahead of World HPP Day on October 30, 2026, the committee has organized a specialized…

The global endocrine community is preparing for a significant shift in professional development and peer-to-peer networking with the announcement of EndoForum Live 2027. Scheduled to take place on January 23, 2027, from 9:00 AM to 2:00 PM ET, this free, virtual, members-only event represents a strategic evolution in how medical societies facilitate the exchange of…

The landscape of modern endocrinology is undergoing a significant transformation, driven by a new generation of physicians who balance rigorous clinical standards with digital outreach. Dr. Sehrish Waheed, a Las Vegas-based endocrinologist known to the digital world as “@NoSugarMD,” has emerged as a prominent figure in this shift. By documenting her journey through the American…